VIR financials
Vir Biotechnology (VIR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
VIR income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $68.56M | $56.85M | -$468.02M | -$437.99M | -3.16 |
| 2024 | $74.20M | $58.80M | -$523.42M | -$521.96M | -3.83 |
| 2023 | $86.18M | $63.96M | -$661.00M | -$615.06M | -4.59 |
| 2022 | $1.62B | $1.45B | $833.07M | $515.84M | 3.83 |
| 2021 | $1.10B | $1.02B | $420.75M | $528.58M | 3.96 |
| 2020 | $76.37M | $0.00 | -$296.15M | -$298.67M | -2.51 |
- VIR revenue was $68.56M in fiscal 2025, net income -$437.99M.
Updated 2026-11-03 13:29 UTC